Literature DB >> 9031447

Ongoing prothrombotic state in the portal circulation of cirrhotic patients.

F Violi1, D Ferro, S Basili, R Lionetti, E Rossi, M Merli, O Riggio, M Bezzi, L Capocaccia.   

Abstract

Portal thrombosis may complicate the clinical course of cirrhosis, but the pathophysiologic mechanism is unclear. Aim of the study was to evaluate the behavior of clotting system and endotoxemia in portal vein and in peripheral circulation of 11 cirrhotic patients undergoing transjugular port-systemic shunt (TIPS). Portal blood showed higher values of F1 + 2 [Median (range): 2.5 (1.1-5.3) vs. 1.1 (0.6-2.1) nM, p < 0.01], D-dimer [765 (184-1713) vs. 192 (64-813) ng/ml, p < 0.01] and endotoxemia [31 (16-47.2) vs. 13.7 (7.5-23.5) pg/ml, p < 0.01] than peripheral circulation. In the portal vein, all but one sample had F1 + 2 > 1.2 nM (upper limit of control values), all but one had D-dimer > 216 mg/dl (mean + 2 SD of controls) and 100% had values of endotoxemia > 9.6 pg/ml (upper limit of control values). Fibrinogen was lower in the portal circulation compared to peripheral circulation but the difference was not significant [85 (58-195) vs. 134 (75-244) mg/dl, p > 0.05]. Endotoxemia was directly correlated with F1 + 2 (Rho = 0.92 p < 0.006) and D-dimer (Rho = 0.93, p < 0.005). This study shows that an ongoing prothrombotic state is present in the portal circulation of cirrhotic patients and may play a pivotal role in the thrombotic episodes occurring in this clinical setting.

Entities:  

Mesh:

Year:  1997        PMID: 9031447

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  26 in total

Review 1.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Portal vein thrombosis in cirrhosis: Controversies and latest developments.

Authors:  Damian J Harding; M Thamara P R Perera; Frederick Chen; Simon Olliff; Dhiraj Tripathi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 3.  Portal vein thrombosis in cirrhosis.

Authors:  Kaiser Raja; Mathew Jacob; Sonal Asthana
Journal:  J Clin Exp Hepatol       Date:  2013-12-31

Review 4.  Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms.

Authors:  Wasim A Dar; Elise Sullivan; John S Bynon; Holger Eltzschig; Cynthia Ju
Journal:  Liver Int       Date:  2019-04-02       Impact factor: 5.828

5.  Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.

Authors:  S Basili; V Raparelli; L Napoleone; G Talerico; G R Corazza; F Perticone; D Sacerdoti; A Andriulli; A Licata; A Pietrangelo; A Picardi; G Raimondo; F Violi
Journal:  Am J Gastroenterol       Date:  2017-12-19       Impact factor: 10.864

6.  Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients.

Authors:  Jonathan G Stine; Shawn J Pelletier; Timothy M Schmitt; Robert J Porte; Patrick G Northup
Journal:  HPB (Oxford)       Date:  2015-12-10       Impact factor: 3.647

7.  Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995. 1963 to 1995: 449 patients.

Authors:  R A O'Reilly
Journal:  West J Med       Date:  1998-08

8.  Thrombocytopenia in Chronic Liver Disease and the Role of Thrombopoietin Agonists.

Authors:  Jennifer B Miller; Esteban J Figueroa; Rebecca M Haug; Neeral L Shah
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-06

Review 9.  Portal vein thrombosis in liver cirrhosis.

Authors:  Filippo Luca Fimognari; Francesco Violi
Journal:  Intern Emerg Med       Date:  2008-02-15       Impact factor: 3.397

10.  Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.

Authors:  Francesco Violi; Gino Roberto Corazza; Stephen Hugh Caldwell; Francesco Perticone; Angelo Gatta; Mario Angelico; Alessio Farcomeni; Michela Masotti; Laura Napoleone; Annarita Vestri; Valeria Raparelli; Stefania Basili
Journal:  Intern Emerg Med       Date:  2016-03-30       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.